Tiotropium Respimat® in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials

Felix Ratjen*, Paul Koker, David E. Geller, Berengere Langellier-Cocteaux, Florence Le Maulf, Sabine Kattenbeck, Petra Moroni-Zentgraf, J. Stuart Elborn

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)
488 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Tiotropium Respimat® in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science